{"id":4995,"date":"2022-01-31T12:27:00","date_gmt":"2022-01-31T12:27:00","guid":{"rendered":"https:\/\/adreshe.com\/?p=4995"},"modified":"2024-09-09T12:33:13","modified_gmt":"2024-09-09T12:33:13","slug":"economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis","status":"publish","type":"post","link":"https:\/\/adreshe.com\/en\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/","title":{"rendered":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis"},"content":{"rendered":"<p>Bellone M., Pradelli L., Tavarozzi R., Ladetto M., Nepoti G. , E. Guardalben, D. Ghislieri. \u2013 Farmeconomia. Health economics and therapeutic pathways 2022; 23(1): 85-95<\/p>","protected":false},"excerpt":{"rendered":"<p>Bellone M., Pradelli L., Tavarozzi R., Ladetto M., Nepoti G. , E. Guardalben, D. Ghislieri. \u2013 Farmeconomia. Health economics and therapeutic pathways 2022; 23(1): 85-95<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57,8],"tags":[],"class_list":["post-4995","post","type-post","status-publish","format-standard","hentry","category-57","category-articoli"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adreshe.com\/en\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres\" \/>\n<meta property=\"og:description\" content=\"Bellone M., Pradelli L., Tavarozzi R., Ladetto M., Nepoti G. , E. Guardalben, D. Ghislieri. \u2013 Farmeconomia. Health economics and therapeutic pathways 2022; 23(1): 85-95\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adreshe.com\/en\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adres\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-31T12:27:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-09T12:33:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/person\\\/9099f9d808254da1a35de846dff135f5\"},\"headline\":\"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis\",\"datePublished\":\"2022-01-31T12:27:00+00:00\",\"dateModified\":\"2024-09-09T12:33:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/\"},\"wordCount\":41,\"publisher\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\"},\"articleSection\":[\"2022\",\"ARTICOLI\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/\",\"url\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/\",\"name\":\"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#website\"},\"datePublished\":\"2022-01-31T12:27:00+00:00\",\"dateModified\":\"2024-09-09T12:33:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/adreshe.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#website\",\"url\":\"https:\\\/\\\/adreshe.com\\\/\",\"name\":\"Adres\",\"description\":\"Health Economics &amp; Outcomes Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/adreshe.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\",\"name\":\"Adres - Health Economic & Outcome Research\",\"url\":\"https:\\\/\\\/adreshe.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/adreshe.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Logo-AdRes-rgb.png\",\"contentUrl\":\"https:\\\/\\\/adreshe.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Logo-AdRes-rgb.png\",\"width\":1754,\"height\":874,\"caption\":\"Adres - Health Economic & Outcome Research\"},\"image\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/person\\\/9099f9d808254da1a35de846dff135f5\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/adreshe.com\\\/en\\\/author\\\/ecappelluti_vr1q5683\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adreshe.com\/en\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/","og_locale":"en_US","og_type":"article","og_title":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres","og_description":"Bellone M., Pradelli L., Tavarozzi R., Ladetto M., Nepoti G. , E. Guardalben, D. Ghislieri. \u2013 Farmeconomia. Health economics and therapeutic pathways 2022; 23(1): 85-95","og_url":"https:\/\/adreshe.com\/en\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/","og_site_name":"Adres","article_published_time":"2022-01-31T12:27:00+00:00","article_modified_time":"2024-09-09T12:33:13+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/#article","isPartOf":{"@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/"},"author":{"name":"admin","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5"},"headline":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis","datePublished":"2022-01-31T12:27:00+00:00","dateModified":"2024-09-09T12:33:13+00:00","mainEntityOfPage":{"@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/"},"wordCount":41,"publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"articleSection":["2022","ARTICOLI"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/","url":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/","name":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis - Adres","isPartOf":{"@id":"https:\/\/adreshe.com\/#website"},"datePublished":"2022-01-31T12:27:00+00:00","dateModified":"2024-09-09T12:33:13+00:00","breadcrumb":{"@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/adreshe.com\/economic-consequences-of-administering-obinutuzumab-as-a-short-duration-infusion-in-italian-patients-with-advanced-follicular-lymphoma-a-cost-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/adreshe.com\/"},{"@type":"ListItem","position":2,"name":"Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis"}]},{"@type":"WebSite","@id":"https:\/\/adreshe.com\/#website","url":"https:\/\/adreshe.com\/","name":"Adres","description":"Health Economics &amp; Outcomes Research","publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adreshe.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/adreshe.com\/#organization","name":"Adres - Health Economic & Outcome Research","url":"https:\/\/adreshe.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/","url":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","contentUrl":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","width":1754,"height":874,"caption":"Adres - Health Economic & Outcome Research"},"image":{"@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/adreshe.com\/en\/author\/ecappelluti_vr1q5683\/"}]}},"_links":{"self":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/4995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/comments?post=4995"}],"version-history":[{"count":2,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/4995\/revisions"}],"predecessor-version":[{"id":5000,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/4995\/revisions\/5000"}],"wp:attachment":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/media?parent=4995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/categories?post=4995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/tags?post=4995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}